Tweets
Obesity is assoc w higher CRP.
Losing weight lowers CRP RWCS24 https://t.co/Gc6TKtmOgI
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Higher adipose in RA linked to atherosclerosis but protects against erosions RWCS24 https://t.co/qsFMhj4LyZ
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Dr Jon Giles at #RWCS24 shows adipose tissue produces pro inflammatory ytokines https://t.co/8NMAWIODuQ
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Co-management of Psoriatic Disease
It is a common clinical scenario to see someone with both severe psoriatic arthritis and skin psoriasis. Co-management with dermatology optimises the care of this patient group.
https://t.co/8xZ9ZBpa3O https://t.co/xMYLhxA1j1
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
RWCS 2024 is Kicked off by Dr Artie Kavaugh in Maui. Watch for tweets from #RWCS24 #ValentinesDay https://t.co/iPKIfXphrx
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
NJ leads on prior authorization legislation:
- Prior auth turnaround time is 24 hrs urgent requests
- Peer-to-peers for denials involves same specialty MD
- Transparency: companies have to share data on denials/reasons.
(29 states w/ active bills/reforms) https://t.co/pZlyW68DDL https://t.co/uc251qj2Gf
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
JAKi Safety and Efficacy in bDMARD-IR Patients With RA
This ACR 2023 poster shows SELECT-CHOICE outcomes through Week 204 from bDMARD-IR patients with RA, including TNFi-IR subgroup outcomes.
Sponsored by AbbVie US Medical Affairs. https://t.co/3fJsZ4IMjG https://t.co/xaKlZPmDkC
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Tonix is developing a drug, TNX-102 SL, that targets poor sleep quality for fibromyalgia. Phase 3 trial in FM (457 pts) showed TNX-102 SL was better (vs PBO) & improved sleep quality (p=0.0000001 & improved daily pain (p=0.00005) https://t.co/QpgET61Vec https://t.co/zphVycL3rg
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Taiwan National Health claims data looked at drugs & gout flares. Signif increase flares were seen w/ ASA, thiazides, loop diuretics, ethambutol, pyrazinamide (1.15-3.35) & metformin (SR=1.14). Lower risk w/ fenofibrate (SR=0.60) & losartan (0.92) https://t.co/1RUw1Q2EBz https://t.co/D2E68kuuwN
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Microbiome study (stool- & saliva) in 144 DMARD-naïve RA pts. Samples 6 wks after DMARD Rx. In those achieving MCID, stool microbes decreased (Prevotella, Streptococcus). Baseline microbiota in DMARD-naïve pts indicated future response https://t.co/PQJEp3bNBE https://t.co/jV5SeNd21z
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
85 Chinese SLE pts study of Dz activity & depression/ anxiety assessed by PHQ-9 & GAD-7. Good correlation betw SLEDAI-2K & SLE-DAS (r=0.76);also w/ mod-high activity (r=0.79), but less w/ mild Dz/remission (r=0.45). Anxiety/Depresion did not affect scores https://t.co/eyhgiYxf3P https://t.co/5LHg3HO21v
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Retro study of 1,169 pts (age 66 yrs) receiving intra-articular steroids & changes on A1C. A1C increases were assoc w/ higher baseline A1C (OR 1.84) for A1C 7–8 (vs <7%) or A1C >8% (OR 4.8 ). YET most patients do not experience increase A1C after IACS https://t.co/t3OWYeT1gr https://t.co/qi5qIUZQdZ
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago


